Protein-Tyrosine Kinases

Name
Protein-Tyrosine Kinases
Accession Number
DBCAT002978
Description

Protein kinases that catalyze the PHOSPHORYLATION of TYROSINE residues in proteins with ATP or other nucleotides as phosphate donors.

Drugs
DrugDrug Description
Nelipepimut-SInvestigated for use/treatment in prostate cancer and breast cancer.
VEGFR2-169VEGFR2-169 is under investigation in clinical trial NCT00655785 (Antiangiogenic Peptide Vaccine Therapy With Gemcitabine in Treating Patient With Pancreatic Cancer (Phase1/2)).
Drugs & Drug Targets
DrugTargetType
Nelipepimut-SHLA class I histocompatibility antigen, A-2 alpha chaintarget
Nelipepimut-SHLA class I histocompatibility antigen, A-3 alpha chaintarget